| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Goat |
| Applications | ELISA,WB-Ce |
| Brand: | Abnova |
| Reference: | PAB6721 |
| Product name: | MAPK1 polyclonal antibody |
| Product description: | Goat polyclonal antibody raised against synthetic peptide of MAPK1. |
| Gene id: | 5594 |
| Gene name: | MAPK1 |
| Gene alias: | ERK|ERK2|ERT1|MAPK2|P42MAPK|PRKM1|PRKM2|p38|p40|p41|p41mapk |
| Gene description: | mitogen-activated protein kinase 1 |
| Immunogen: | A synthetic peptide corresponding to human MAPK1. |
| Immunogen sequence/protein sequence: | CAAGPEMVRGQVF |
| Protein accession: | NP_002736;NP_620407 |
| Form: | Liquid |
| Concentration: | 0.5 mg/mL |
| Recommend dilutions: | ELISA (1:8000) Western Blot (0.5-2 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In Tris saline, pH 7.3 (0.5% BSA, 0.02% sodium azide) |
| Storage instruction: | Store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Goat |
| Antigen species / target species: | Human |
| Specificity: | This antibody is expected to recognize an epitope corresponding to aa 9-19 of both reported protein isoforms of human ERK2/MAPK1 protein. |
| Reactivity: | Human |
| Application image: | ![]() |
| Application image note: | MAPK1 polyclonal antibody (Cat # PAB6721) (0.5 ug/mL) staining of HepG2 lysate (35 ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. |
| Applications: | ELISA,WB-Ce |
| Shipping condition: | Dry Ice |
| Publications: | EPO receptor-mediated ERK kinase and NF-kappaB activation in erythropoietin-promoted differentiation of astrocytes.Lee SM, Nguyen TH, Park MH, Kim KS, Cho KJ, Moon DC, Kim HY, Yoon DY, Hong JT. Biochem Biophys Res Commun. 2004 Aug 6;320(4):1087-95. |